A report in The Harvard Gazette... Evidence from a study of more than 130,000 people suggests that two to three cups of coffee a day can reduce dementia risk and slow cognitive decline.
The research — published in JAMA and led by investigators from Mass General Brigham, Harvard T.H. Chan School of Public Health, and the Broad Institute of MIT and Harvard — analyzed data from the Nurses’ Health Study and Health Professionals Follow-Up Study.
“When searching for possible dementia prevention tools, we thought something as prevalent as coffee may be a promising dietary intervention — and our unique access to high-quality data through studies that have been going on for more than 40 years allowed us to follow through on that idea,” said senior author Daniel Wang, associate scientist with the Channing Division of Network Medicine in the Mass General Brigham Department of Medicine and assistant professor at Harvard Medical School. Wang is also an assistant professor in the Department of Nutrition at Harvard Chan School and an associate member at the Broad Institute.
“While our results are encouraging, it’s important to remember that the effect size is small and there are lots of important ways to protect cognitive function as we age. Our study suggests that caffeinated coffee or tea consumption can be one piece of that puzzle.”
Early prevention is especially crucial for dementia, since current treatments are limited and typically offer only modest benefit once symptoms appear. Focus on prevention has led researchers to investigate the influences of lifestyle factors like diet on dementia development.
Coffee and tea contain bioactive ingredients like polyphenols and caffeine, which have emerged as possible neuroprotective factors that reduce inflammation and cellular damage while protecting against cognitive decline. Though promising, findings about the relationship between coffee and dementia have been inconsistent, as studies have had limited follow-up and insufficient detail to capture long-term intake patterns, differences by beverage type, or the full continuum of outcomes — from early subjective cognitive decline to clinically diagnosed dementia.
Data from Nurses’ Health Study and Health Professionals Follow-Up Study help to overcome these challenges. Participants repeated assessments of diet, dementia, subjective cognitive decline, and objective cognitive function, and were followed for up to 43 years. Researchers compared how caffeinated coffee, tea, and decaffeinated coffee influenced dementia risk and cognitive health of each participant.
Of the 131,821 participants, 11,033 developed dementia. Both male and female participants with the highest intake of caffeinated coffee had an 18 percent lower risk of dementia compared with those who reported little or no caffeinated coffee consumption. Caffeinated coffee drinkers also had lower prevalence of subjective cognitive decline (7.8 percent versus 9.5 percent). By some measurements, those who drank caffeinated coffee also showed better performance on objective tests of overall cognitive function.
Higher tea intake showed similar results, while decaffeinated coffee did not — suggesting that caffeine may be the active factor producing these neuroprotective results, though further research is needed to validate the responsible factors and mechanisms.
The cognitive benefits were most pronounced in participants who consumed two to three cups of caffeinated coffee or one to two cups of tea daily. Contrary to several previous studies, higher caffeine intake did not yield negative effects — instead, it provided similar neuroprotective benefits to the optimal dosage.
Getting your caffeine from coffee rather than carbonated sodas would seem sensible. This was a large sample size, over a long time, so not easily dismissed.
“We also compared people with different genetic predispositions to developing dementia and saw the same results — meaning coffee or caffeine is likely equally beneficial for people with high and low genetic risk of developing dementia,” said lead author Yu Zhang, a student at Harvard Chan School and a research trainee at Mass General Brigham.
Seems to have been a robust research criteria.
